Cargando…
Can We Treat Neuroinflammation in Alzheimer’s Disease?
Alzheimer’s disease (AD), considered the most common type of dementia, is characterized by a progressive loss of memory, visuospatial, language and complex cognitive abilities. In addition, patients often show comorbid depression and aggressiveness. Aging is the major factor contributing to AD; howe...
Autores principales: | Sánchez-Sarasúa, Sandra, Fernández-Pérez, Iván, Espinosa-Fernández, Verónica, Sánchez-Pérez, Ana María, Ledesma, Juan Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699542/ https://www.ncbi.nlm.nih.gov/pubmed/33228179 http://dx.doi.org/10.3390/ijms21228751 |
Ejemplares similares
-
Targeting Neuroinflammation with Abscisic Acid Reduces Pain Sensitivity in Females and Hyperactivity in Males of an ADHD Mice Model
por: Meseguer-Beltrán, María, et al.
Publicado: (2023) -
Targeting Neuroinflammation to Treat Alzheimer’s Disease
por: Ardura-Fabregat, A., et al.
Publicado: (2017) -
ABA Supplementation Rescues IRS2 and BDNF mRNA Levels in a Triple-Transgenic Mice Model of Alzheimer’s Disease
por: Alves-Borba, Laryssa, et al.
Publicado: (2023) -
The Influence of Nutrition in Alzheimer's Disease: Neuroinflammation and the Microbiome vs. Transmissible Prion
por: Bello-Corral, Laura, et al.
Publicado: (2021) -
The effect of abscisic acid chronic treatment on neuroinflammatory markers and memory in a rat model of high-fat diet induced neuroinflammation
por: Sánchez-Sarasúa, Sandra, et al.
Publicado: (2016)